IGHE and congenital rubella syndrome: Only two randomized controlled studies have so far been conducted relating macrolides treatment on CRS patients measuring IgE levels at the time of enrollment: Wallwork et al.31 reported that macrolides have benefits especially on CRS patients with low levels of IgE, but Hexel et al.32 did not found such advantage in their similar patients.